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Abstract:  
 Stimulant medications are most often prescribed for the treatment of attention 
deficit hyperactivity disorder (ADHD) and fetal alcohol syndrome (FAS).  However, 
about 20% of the children taking stimulants do not have much symptom relief or they 
suffer from side effects.  As a result, adjunctive therapy is often recommended.  One 
approach is to prescribe Intuniv
®
 (guanfacine) with an ADHD stimulant medication such 
as Adderall
®
 (amphetamine).  Many research studies report that Intuniv
®
 given in 
combination with a stimulant leads to significant improvements in ADHD and 
impulsivity symptoms.  Therefore, the purpose of this research is to develop an HPLC 
method to simultaneously determine the concentration of amphetamine and guanfacine in 
dosage form, which could then be used in the analysis of biological fluids. 
Introduction: 
 The research being conducted in this project has not been the only kind done. 
There has been much research done on the basis of determination or identification of 
amphetamine and/or guanfacine in biological samples. Throughout all the research, there 
has been one common motive: develop a method of determination that is effective 
enough for guanfacine or amphetamine to be quantified in the biological samples. The 
various methods for determining guanfacine specifically include high-performance liquid 
chromatography
1,2
, spectrofluorimetric determination
3
, dried blood spot technology
4
, 
liquid chromatography-tandem mass spectrometry
5
, gas chromatography-mass 
spectrometry
6
, and spectrophotometry
7
. The methods for amphetamine are gas 
chromatography-mass spectrometry
8-12
, derivatization and gas chromatography-mass 
spectrometry
13
, liquid chromatography-tandem mass spectrometry
14
, liquid 
chromatography on a chiral stationary phase
15
, solid phase extraction and ion-pair 
chromatography-electrospray-tandem mass spectrometry
16
, pipette tip solid-phase 
extraction and gas chromatography-mass spectrometry
17
, and the use of a gold 
electrode
18
. In all of the previously mentioned methods, separation had been 
accomplished, though not all produced it simultaneously. However, obtaining the initial 
biological sample that is necessary for most of the methods is largely time consuming and 
difficult because access to the samples are extremely limited in part due to the 
unwillingness of institutions and medical professionals to share samples with one 
another
19
. 
 Guanfacine, which is a non-stimulant, is thought to affect receptors in certain 
areas of the brain that strengthen working memory, reduce distraction, and improve 
attention and impulse control
20
.  
 
Figure 1. Structure of Guanfacine Hydrochloride 
It is also the main component in Intuniv
®
. Intuniv is prescribed as a treatment to control 
symptoms of attention deficit hyperactivity disorder (ADHD). It can further be prescribed 
for high blood pressure. 
 Amphetamine is a synthetic stimulant of the central nervous system and is used to 
increase the synaptic activity of certain neurotransmitters
21
. Although it can be addictive, 
it is legally used as part of a treatment plan (along with guanfacine) in treating kids with 
ADHD. It works by restoring the balance of natural substances in the brain and helps 
with the ability to pay attention, focus, and remain still. Amphetamine is the drug used to 
make Adderall® along with dextroamphetamine. It is not only prescribed for helping 
ADHD, but is also used to treat sleeping disorders and to help people stay awake
22,23
.  
Background/Purpose: 
 ADHD is the most commonly diagnosed neurobehavioral disorder in children. 
Symptoms can include hyperactivity, inability to control impulses, and inattention. This 
disorder mainly affects children, but can continue into adulthood
24
. It is clear the 
previously noted behaviors can impair and interfere with home life, social settings, and 
academic performance, but can be subdued through the use of medication. Over the past 
decade, there has been a dramatic increase in the diagnosis of ADHD. In 2005, according 
to the National Survey of Children’s Health, the percentage of children ages 4-17 years 
who were diagnosed with ADHD increased from 7.8% to 9.5% during 2003-2007, 
indicating a 21.8% increase in four years. Furthermore, among children with current 
ADHD, 66.3% were taking medication. Thus, 4.8% of all children were taking 
medication (around 2.7 million)
25
. Although it can usually be discovered or diagnosed 
during a child’s early life, how young is too young and are children being diagnosed with 
insufficient evaluation?  
 There are various types of ADHD: inattention, hyperactivity, and impulsivity
26
. 
The different types are categorized based on the severity of the symptoms observed.  For 
example, a child with inattention may not like to do things the require sitting still, 
whereas, a child with hyperactivity, rarely remains seated if at all. Nonetheless, the 
symptoms are all similar, though may vary, as a person gets older. Symptoms can include 
but are not limited to anxiety, procrastination, mood swings, and depression. A specific 
cause of ADHD has not been identified, but researchers believe it can be attributed to 
several things such as heredity, poor nutrition, or chemical imbalances. It cannot be 
prevented or cured, but spotting it early on can help ensure proper management of 
symptoms.  
 The management of symptoms can be done in the form of medication. Often, 
stimulants are prescribed to help control the hyperactive and impulsive behaviors, while 
also increasing the attention span. Some examples include Adderall
®
, Ritalin
®
, or 
Concerta
®
. Nonetheless, stimulants may not work for every person, or may not work 
favorably alone. Therefore, non-stimulant medication can be prescribed as well; this is 
known as adjunctive therapy. Some examples include Intuniv
®
 and Strattera
®
. 
Medication is not the only form of treatment that can be used to help manage ADHD. 
Therapy such as special education or behavior modification can help children learn more 
efficiently in school and replace inappropriate behavior with good behavior.  
 For the research being conducted in this experiment, the drugs in focus will 
include Intuniv
®
 and Adderall
®
. More specifically, HPLC or high performance liquid 
chromatography, will be used to simultaneously determine the concentrations of both 
drugs to further explore how well adjunctive therapy works and how they affect their 
purpose of treatment. 
 
Table 1 – Percentage of Students Prescribed Adderall
® 
for ADHD 
 
 Adderall
®
 is a commonly prescribed drug to help mange the affects of ADHD. It 
is a combination of amphetamine and dextroamphetamine. They are central nervous 
stimulants that affect chemicals in the brain and nerves that contribute to the 
hyperactivity and impulsivity experienced by children who suffer from ADHD. It is 
available either as an immediate release tablet or extended release capsules. It works by 
increasing the activity of the neurotransmitters norepinephrine and dopamine in the 
brain
27
. It is generally well tolerated in children and can be effective in treating ADHD 
symptoms. Specifically, pharmaceutical amphetamines have the potential to improve 
brain development and nerve growth. Also, they improve stamina, endurance, and 
reaction time due to effluxion of dopamine in the central nervous system. Studies have 
also shown that long-term usage of amphetamines can decrease abnormalities in the 
structure of the brain as well as the function in several areas of the brain. Furthermore, 
approximately 80% of people who have used this stimulant have seen improvements in 
ADHD symptoms
28
. If children continue to use stimulant medication, they could have not 
only better relationships with their family, but also perform better in school and be less 
distracted.  
 On the other hand, Intuniv
®
 is similar to Adderall
®
 in its function to help treat 
ADHD, but it is not a stimulant drug. It is an extended-release form of guanfacine 
hydrochloride. It has the ability to strengthen parts of the brain that regulate attention and 
behavior, specifically the prefrontal cortical region
29
. In adjunctive therapy, gaunfacine is 
used in juxtaposition with stimulants such as amphetamines, to enhance therapeutic 
actions. While relatively new, it is currently approved and marketed in the U.S. as 
Intuniv
®
.  
 High performance liquid chromatography is basically an improved version of 
column chromatography. A solvent is forced through a column under high pressures, 
which makes it extremely quick and efficient. It also allows for the usage of much 
smaller particles for the column packing material. This is important because the more 
small particles that are used increases the surface area which ultimately increases the 
probability for more interactions between the stationary phase and the mobile phase. This 
allows for better separation of the components in a mixture
30
. This technique is mostly 
used in the analytical chemistry field, and as given by the previous description, it is used 
to separate and identify each component in a mixture. This particular method is 
imperative to the study being conducted because it is used to “test the products and to 
detect the raw ingredient used to make them.”
31
 The biggest benefit from utilizing this 
method is obtaining a better understanding of the structure, impurities, and degradation, 
of a drug product that is not just limited to synthetic drugs, but also herbal medications. 
 
 
 
Figure 2. Actual HPLC instrument used in the experiment 
 
 
 
Figure 3. Schematic of the HPLC 
 
Procedure: 
 Two different forms of guanfacine were used in the experiment: tablet and 
reference standard (powder). 
 
Figure 4. Guanfacine tablet 
 
First, the tablet was made into a solution in order for it to be analyzed by HPLC. The 
diluent was prepared by mixing 14 mL of water and 6 mL of acetonitrile in a beaker. 
Next, the guanfacine tablet (2 mg) was crushed into a fine powder. The powder was then 
dissolved in 10 mL of diluent. Once the solution was both prepared, it was stirred for 
about ten minutes using a magnetic stir plate due to its low solubility. Next, the dilutions 
were made: 1:5 (0.04 mg/mL), 1:10 (0.02 mg/mL), 1:20 (0.01 mg/mL), 1:50 (0.004 
mg/mL), and 1:100 (0.002 mg/mL). Each dilution was sequentially injected three times 
into the HPLC instrument.  
 The guanfacine powder (reference standard) sample preparation began with 
preparing the solution it would be dissolved in, which is also the diluent. The solution 
was made by combining 42 mL of water and 18 mL of acetonitrile and mixing well. To 
dissolve the powder, 50 mL was used for the sample. What was left of the diluent was 
used to make five more dilutions: (1:5 (0.2 mg/mL), 1:10 (0.1 mg/mL), 1:20 (0.05 
mg/mL), 1:50 (0.02 mg/mL), and 1:100 (0.01 mg/mL). As previously done, each sample 
was injected three times.  
Experimental: 
Chemicals and Reagents 
 The HPLC mobile phase utilized 80% acetonitrile and 20% 6.25 mM sodium 
phosphate with a pH adjusted to 3.2 using phosphoric acid (acetonitrile/sodium phosphate 
source: Fisher Scientific
®
). The source of both the reference standard and tablets is Sigma 
Aldrich
®
.  
Equipment 
 The HPLC instrument was composed of a pump (Shimadzu DGU-20 AS), a 
column (Phenomenex Synergi 4u Hydro-RP 80A, 150 x 4.60 mm 4u micron), UV 
detector (Shimadzu SPD-20A), and Microsoft Excel data system. 
HPLC Method 
 Through the use of a polar mobile phase of 80% acetonitrile and 6.25 mM sodium 
phosphate (pH 3.2), the solution was eluted through the column at a flow rate of 0.5 
mL/min. The detector was set to a UV wavelength of 220 nm.  
 
 
 
Data/Results: 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 – Guanfacine (0.5 mg/mL) elutes at 4.556 minutes and amphetamine (0.6 mg/mL) elutes at 5.306 
min. 
 
Discussion: 
 The first set of experimental data was collected from the tablet form of 
guanfacine. For each of the concentrations, the standard deviation (STDEV) and the 
relative standard deviation (RSD) was calculated. The calculated values were then used 
to analyze the data along with the error in the data. The values were suitable for some of 
the concentrations while others were not, possibly due to some outliers. Because of this 
error, some modifications need to take place so all the numbers will be more accurate.  
 The second set of experimental data referred to the reference standard used in the 
experiment. One concern regarding the table that stood out was the high value of the RSD 
at 48.2 with the concentration of 0.01. In order to check for possible outliers, a Q test was 
performed. Once the test was complete, the value calculated was compared to a literature 
value at the 99% confidence level. While the RSD was abnormally high, it fell within a 
specified range and was thus determined not to be an outlier. Furthermore, the actual 
calculation of both the standard deviation and the relative standard deviation helped 
examine the accuracy and precision of the measurements taken in the table; it is taught 
that good precision does not always mean good accuracy. The standard deviation is an 
indicator of precision based on the reliability of the experimental results while RSD 
indicates how widely spread the values are from the average. If the standard deviation is 
high, the results will be seemingly unreliable. It is determined by first calculating the 
mean. Then, for each number, subtract the mean and square the result. Finally, work out 
the average of those squared differences. In general terms, precision applies to how well 
the same measurement was delivered repeatedly, while accuracy applies to how close the 
results are to the actual measurement. As far as precision is concerned, the RSD for the 
same concentration repeated in multiples should be below 2%. With a decreased number 
of samples, a precision of 5-10% RSD is generally accepted. Referring to accuracy, the 
percent recovery should be within 90-110% (for spiked samples; this is called spiked 
recovery).  These would represent the concentrations not present on the calibration curve. 
When looking at the linearity of the graphs, it is important to note the correlation 
coefficient, which a measurement of how accurate a linear relationship is. Ideally, 0.98 or 
better is best. For both curves comparing the height and areas, the correlation coefficients 
were within an acceptable range, indicating good measurements. In continuation of the 
analysis, the height and area were observed as being dependent on the concentration. The 
calibration curve showed how the height was more accurate than the area. Also, the limit 
of quantification (LOQ), which is defined as the lowest concentration at which the 
analyte can be detected (concentrations lower are not within the linear range), was 
determined to be the 1:50 (0.02 mg/mL) dilution for the reference standard. 
 The third set of data also concerned the reference standard. The particular set of 
data was of concentrations between the previously recorded data to verify if the height or 
area was better use for the calculation of the concentration. This data was also used to 
calculate the expected concentrations using the calibrations curves. The calculated 
concentrations were lower than normal, which indicated that some alterations could be 
done to produce better results.  
Finally, Figure 5 is an illustration of what an ideal graph of the concentration of 
guanfacine and amphetamine would look like if we were successful in simultaneously 
determining their concentrations.  
Future Work: 
 In the future, it would be nice to develop an HPLC method to simultaneously 
determine guanfacine and amphetamine. The first priority is to find a method to be used 
for amphetamine that is close in relation to the method used for guanfacine. However, the 
method for guanfacine needs to be validated and enhanced for acceptable accuracy and 
precision.  
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